These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33251371)

  • 1. Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19.
    Bhati S
    Heliyon; 2020 Nov; 6(11):e05558. PubMed ID: 33251371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An
    Jamalan M; Barzegari E; Gholami-Borujeni F
    J Proteome Res; 2021 Jan; 20(1):1015-1026. PubMed ID: 33350309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
    Balkrishna A; Mittal R; Arya V
    Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some
    Amin SA; Ghosh K; Gayen S; Jha T
    J Biomol Struct Dyn; 2021 Aug; 39(13):4764-4773. PubMed ID: 32568618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease.
    Bosken YK; Cholko T; Lou YC; Wu KP; Chang CA
    Front Mol Biosci; 2020; 7():174. PubMed ID: 32850963
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Huynh T; Cornell W; Luan B
    Front Chem; 2020; 8():624163. PubMed ID: 33614597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
    Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
    ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors.
    Henderson JA; Verma N; Harris RC; Liu R; Shen J
    J Chem Phys; 2020 Sep; 153(11):115101. PubMed ID: 32962355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
    Amin SA; Banerjee S; Ghosh K; Gayen S; Jha T
    Bioorg Med Chem; 2021 Jan; 29():115860. PubMed ID: 33191083
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sanachai K; Mahalapbutr P; Sanghiran Lee V; Rungrotmongkol T; Hannongbua S
    J Phys Chem B; 2021 Dec; 125(50):13644-13656. PubMed ID: 34904832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking.
    Castillo-Campos L; Velázquez-Libera JL; Caballero J
    Front Mol Biosci; 2023; 10():1215499. PubMed ID: 37426421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies.
    Rudrapal M; Celik I; Chinnam S; Azam Ansari M; Khan J; Alghamdi S; Almehmadi M; Zothantluanga JH; Khairnar SJ
    Saudi J Biol Sci; 2022 May; 29(5):3456-3465. PubMed ID: 35233172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation.
    Tian X; Zhao Q; Chen X; Peng Z; Tan X; Wang Q; Chen L; Yang Y
    Front Pharmacol; 2022; 13():817715. PubMed ID: 35264955
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone.
    Jiang H; Yang P; Zhang J
    Front Chem; 2022; 10():822785. PubMed ID: 35281561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation.
    Natesh J; Mondal P; Penta D; Abdul Salam AA; Meeran SM
    Comput Biol Med; 2021 Jan; 128():104102. PubMed ID: 33190011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.
    Osipiuk J; Azizi SA; Dvorkin S; Endres M; Jedrzejczak R; Jones KA; Kang S; Kathayat RS; Kim Y; Lisnyak VG; Maki SL; Nicolaescu V; Taylor CA; Tesar C; Zhang YA; Zhou Z; Randall G; Michalska K; Snyder SA; Dickinson BC; Joachimiak A
    Nat Commun; 2021 Feb; 12(1):743. PubMed ID: 33531496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design.
    Rut W; Lv Z; Zmudzinski M; Patchett S; Nayak D; Snipas SJ; El Oualid F; Huang TT; Bekes M; Drag M; Olsen SK
    bioRxiv; 2020 Apr; ():. PubMed ID: 32511411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies.
    Baildya N; Khan AA; Ghosh NN; Dutta T; Chattopadhyay AP
    J Mol Struct; 2021 Mar; 1227():129390. PubMed ID: 33041371
    [No Abstract]   [Full Text] [Related]  

  • 20. Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking.
    Valdés-Albuernes JL; Díaz-Pico E; Alfaro S; Caballero J
    Front Mol Biosci; 2024; 11():1374364. PubMed ID: 38601323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.